Peter Velazquez
About Peter Velazquez
Peter Velazquez is the Director of Analytical Development at Instil Bio, specializing in immune regulation and immunotherapy. He has held various academic and industry positions, including roles at Amgen and Atara Biotherapeutics, and has a strong publication record in top-tier journals.
Current Role at Instil Bio
Peter Velazquez serves as the Director of Analytical Development at Instil Bio. He has held this position since 2020, contributing to the company's focus on innovative therapies in the field of immunotherapy. His role involves overseeing analytical strategies and methodologies that support the development of advanced therapeutic products.
Previous Experience at Amgen
Peter Velazquez worked at Amgen in various capacities. He served as Principal Scientist from 2012 to 2016, where he led projects in analytical development. Prior to this, he was a Senior Scientist and Team Lead from 2016 to 2018 in the San Francisco Bay Area, focusing on advancing scientific research and product development.
Academic Background and Teaching Experience
Peter Velazquez has an extensive academic background. He earned a Ph.D. in Cellular and Molecular Pathology from the David Geffen School of Medicine at UCLA from 2002 to 2005. He also studied Biomedical Sciences with a focus on Immunology at Washington University School of Medicine in St. Louis, obtaining an M.A. from 1997 to 2000. His teaching experience includes positions as an Assistant Professor at the University of Notre Dame and Indiana University School of Medicine, where he contributed to the field of biology and cancer research.
Research and Publication Record
Peter Velazquez has a notable research record in immune regulation and immunotherapy. He has secured grants in these areas and has published in top-tier peer-reviewed journals, focusing on immune regulation. His research contributions have advanced the understanding of immune responses and therapeutic strategies.
Technical Expertise and Specializations
Peter Velazquez possesses significant technical expertise in various advanced imaging and analytical techniques. His skills include multi-photon intravital microscopy, confocal microscopy, and flow cytometry, among others. He specializes in the development of bi-specifics, CAR T cell therapies, and TCR T cell discovery, contributing to innovative therapeutic development in the field of immunotherapy.